The introduction of Retatrutide ZPHC, at a dosage of 120mg, is creating considerable excitement within the weight loss community. This groundbreaking dual GIP and GLP-1 target medication seems to deliver significant improvements in fat shedding compared to previous therapies. Early clinical data have indicated significant decreases in weight , poss